Early Prediction of Outcome in Advanced Head-and-Neck Cancer Based on Tumor Blood Volume Alterations During Therapy: A Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1287-1290

  Cao, Yue ^a,b   Popovtzer, Aron ^a   Li, Diana ^a   Chepeha, Douglas B ^a   Moyer, Jeffrey S ^a   Prince, Mark E ^a   Worden, Francis ^b   Teknos, Theodoros ^a   Bradford, Carol ^a   Mukherji, Suresh K ^b   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Head and neck cancer; Imaging; Perfusion; Radiotherapy

Indexed keywords

BLOOD; HEMODYNAMICS; MILITARY CONSTRUCTION EQUIPMENT; OXYGEN; RADIOTHERAPY;

AFTER INITIATIONS; BLOOD FLOWS; DYNAMIC CONTRASTS; GROSS TUMOR VOLUMES; HEAD AND NECK CANCER; IMAGING; LOCAL CONTROLS; LOCAL FAILURES; MRI SCANS; NECK CANCERS; PERFUSION; PROSPECTIVE STUDIES; REGIONAL FAILURES; TUMOR BLOOD VOLUMES; TUMOR VOLUMES;

TUMORS;

CARBOPLATIN; CETUXIMAB; CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD VOLUME; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LOADING DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR VOLUME;

ADULT; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD VOLUME; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY DOSAGE; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 56349171259     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.024     Document Type: Article

References (15)

1. Worden F.P., Kumar B., Lee J.S., et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number. J Clin Oncol 26 (2008) 3138-3146
2. Stadler P., Becker A., Feldmann H.J., et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44 (1999) 749-754
3. Brizel D.M., Dodge R.K., Clough R.W., et al. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53 (1999) 113-117
4. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
5. Hermans R., Meijerink M., Van den Bogaert W., et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1351-1356
6. Gandhi D., Chepeha D.B., Miller T., et al. Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 27 (2006) 101-106
7. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24 (2002) 127-135
8. Zima A., Carlos R., Gandhi D., et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol 28 (2007) 328-334
9. Lehtio K., Eskola O., Viljanen T., et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 59 (2004) 971-982
10. 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5 (2005) 152
11. Cao Y., Tsien C.I., Nagesh V., et al. Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT. Int J Radiat Oncol Biol Phys 64 (2006) 876-885
12. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
13. Mullani N.A., Goldstein R.A., Gould K.L., et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 24 (1983) 898-906
14. Hermans R., Lambin P., Van den Bogaert W., et al. Non-invasive tumour perfusion measurement by dynamic CT: Preliminary results. Radiother Oncol 44 (1997) 159-162
15. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26 (2008) 3128-3137